文献速递免疫规划慢病防控与筛查

炎症性风湿病患者流感疫苗接种接受度的预测因素

Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases.
PubMed 文献 · Vaccine · 2018-07-03

2017年7月至10月在维也纳医科大学风湿病门诊对490例接受免疫抑制治疗的炎症性风湿病患者进行问卷调查,2016/17季度流感疫苗接种率为25.3%(124/490),医生推荐是接种的最强预测因素,未接种主要原因为担心副作用和免疫抑制下疫苗无效。

要点

  • 该人群流感疫苗接种率为25.3%(124/490),处于中等水平。
  • 风湿科医生推荐与接种强相关(62% vs 19%,AOR 9.0,95%CI 4.9-16.5)。
  • 全科医生推荐亦与接种相关(57% vs 15%,AOR 6.6,95%CI 4.1-10.8)。

核心结论

  • 炎症性风湿病患者流感疫苗接种率为25.3%,医生推荐对接种状态影响最大。

研究设计与样本

  • 2017年7月至10月在维也纳医科大学风湿病门诊开展的问卷调查,纳入490例接受免疫抑制治疗的炎症性风湿病患者,收集2016/17季度流感疫苗接种情况。

主要发现

  • 2016/17季度流感疫苗接种率为25.3%(n=124/490)。
  • 较高年龄与接种正相关(AOR 5.0,95%CI 2.4-10.4)。
  • 使用生物改善病情抗风湿药与接种正相关(AOR 2.0,95%CI 1.3-3.1)。
  • 全科医生推荐者接种率57% vs 未推荐者15%(AOR 6.6,95%CI 4.1-10.8)。
  • 风湿科医生推荐者接种率62% vs 未推荐者19%(AOR 9.0,95%CI 4.9-16.5)。

临床怎么用

  • 作者结论认为医生推荐流感疫苗对接种状态影响最大。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with inflammatory rheumatic diseases are at higher risk for influenza and current guidelines recommend vaccination for this group of patients. The aim of this study was to evaluate the vaccination coverage and predictors for influenza vaccination among patients with inflammatory rheumatic diseases. METHODS: This survey was conducted at the outpatient rheumatology clinic at the Medical University of Vienna between July and October 2017. All patients diagnosed with an inflammatory rheumatic disease and receiving immunosuppressive therapy were asked to complete a questionnaire about their influenza vaccination status for 2016/17. RESULTS: 490 patients with rheumatic diseases completed a questionnaire (33% male, mean age 55.3 years). The influenza vaccination rate for the previous season was 25.3% (n = 124/490). Predictors for a positive influenza vaccination status were higher age (Adjusted Odds Ratio 5.0, 95% Confidence Interval 2.4-10.4) and treatment with biological disease-modifying antirheumatic drugs (AOR 2.0, 95% CI 1.3-3.1). Patients who received a recommendation for influenza vaccination by their general practitioner were significantly more likely to be vaccinated than those who did not (57% vs. 15%, AOR 6.6, 95% CI 4.1-10.8); even more so if they received a recommendation by their rheumatologist (62% vs. 19%, AOR 9.0, 95% CI 4.9-16.5). The main reasons for patients to decline influenza vaccination were fear of side effects (36%), concerns that vaccination might not be effective due to their immunosuppressed condition (38%) or that it might worsen the rheumatic disease (20%). CONCLUSIONS: A moderate influenza vaccination rate of 25.3% was detected among patients with inflammatory rheumatic diseases. Recommendation of the influenza vaccine by a physician exerts the most effective impact on a positive vaccination status.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Harrison N, Poeppl W, Miksch M, et al. Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases. Vaccine. 2018. PMID: 29980390. doi:10.1016/j.vaccine.2018.06.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。